Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair shedding during Mounjaro treatment is real, more common than the packaging suggests, and almost always temporary. It is not a direct effect of tirzepatide itself but a well-recognised response to rapid weight loss called telogen effluvium — a shift in the hair growth cycle triggered by the physical stress of losing body weight quickly. Understanding what is happening, and why it usually resolves on its own, is the most useful thing to know right now. These are prescription-only medicines assessed on an individual basis by a qualified prescriber; the clinical picture varies between people, and a pharmacist or prescriber is the right person to discuss your specific situation with.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people notice their hair thinning a few months into Mounjaro treatment, the instinct is to blame the medicine. That instinct is understandable — the timing feels obvious. But the mechanism is subtler. Tirzepatide does not damage hair follicles directly. What it does, very effectively, is reduce appetite and energy intake, which leads to meaningful weight loss. That rapid shift in the body's energy balance is interpreted by the hair cycle as a stressor, and a proportion of follicles respond by entering a resting phase earlier than usual.
The result is telogen effluvium: more hairs than normal fall out at roughly the same time, typically two to four months after the triggering event. Because the trigger is the weight loss rather than the molecule, the same pattern appears with other GLP-1 medicines, with bariatric surgery, and after any period of significant calorie restriction. The NHS tirzepatide patient information page lists hair loss under uncommon side effects, which aligns with the SmPC classification, though many clinicians observe it anecdotally in a higher proportion of patients losing weight quickly.
The short answer: it is a side effect of the process, not a sign the medicine is harming you. Worth knowing before you decide to stop treatment based on the mirror alone.
For most people, the shedding peaks and then quietens within three to six months of the triggering period, as weight stabilises and the follicles cycle back into their growth phase. Full density can take longer to return (hair grows roughly one centimetre per month) but regrowth does happen. The follicles are not destroyed; they have paused.
What can prolong the process is ongoing nutritional insufficiency. When calorie intake drops sharply, protein is often the first casualty, and hair follicles are sensitive to protein availability. Iron and zinc deficiencies, which can develop quietly during a calorie deficit, are also recognised contributors. If shedding is persisting well beyond six months, or feels severe, a GP can check ferritin, iron, zinc and thyroid function, other conditions can cause hair thinning independently of weight loss medicine, and it is worth ruling them out.
For a broader look at how tirzepatide affects the body beyond weight reduction, the full overview of Mounjaro's effects covers the wider picture.
There is no clinical shortcut that stops telogen effluvium once it has started, but there are things that support the hair cycle and prevent it from being made worse. Protein adequacy is the most consistently cited factor: aiming for sufficient protein at each meal helps preserve lean mass and gives follicles the building blocks they need. NHS Live Well guidance on healthy eating provides a sensible reference point for dietary foundations alongside any weight-loss programme.
Gentle hair care is common sense: heat styling, tight hairstyles and aggressive brushing can all add mechanical stress to already-vulnerable shafts. Some people also find their hair texture changes during treatment, and if you are noticing dryness alongside shedding, our guide to dry hair on Mounjaro covers what tends to help. Topical minoxidil has evidence for androgenetic alopecia (pattern hair loss) but less specific evidence for telogen effluvium; if it is something you are considering, discuss it with a GP or dermatologist rather than self-treating.
Questions about your specific situation (whether what you are experiencing sounds typical, whether your diet is meeting your needs, whether a dose adjustment might be worth exploring) are exactly the kind of conversation a prescriber should be part of. If you are already on treatment with another provider and want a clinical review, the Mounjaro treatment page explains what that involves at nume. For those looking at costs alongside everything else, the Mounjaro pricing page sets out what is included in a private prescription.
Most hair shedding on Mounjaro does not require urgent attention. But there are scenarios where a conversation with a prescriber or GP should not wait. If you want a fuller picture of what to expect before those conversations, our dedicated guide to Mounjaro and hair covers the topic in detail, including what typical shedding looks like versus patterns that warrant closer attention. If the shedding is severe rather than gradual, if you are noticing bald patches rather than diffuse thinning, if the loss is accompanied by other symptoms such as fatigue, cold intolerance or brittle nails, these point toward a nutritional deficiency or a separate thyroid or autoimmune condition that happens to coincide with your treatment period. It can also help to understand how Mounjaro works and what changes to expect, so you can better judge whether what you are experiencing falls within the expected range.
The MHRA's Yellow Card scheme exists precisely so that patients can report suspected side effects of medicines, including hair changes they believe are connected to tirzepatide. Reporting through Yellow Card adds to the real-world safety picture and helps the regulator track patterns that clinical trials may undercount. You do not need to be certain the medicine caused it, a suspicion is enough to report.
If you have questions about whether Mounjaro is still suitable for you given what you are experiencing, a prescriber can review the full picture. At nume, every repeat order goes through a fresh clinical assessment by a GPhC-registered prescriber (not an automated check) and that is the right moment to raise concerns about how your body is responding. If you are not yet on treatment and want to understand your options, you can start a free consultation to speak with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.